The effect of long term complementary nutritional support via percutaneous jejunostomy after pancreaticoduodenectomy

Phase 4

• Conditions: C25.0; R64; Head of pancreas; Cachexia

• Registration Number: DRKS00010237
• Lead Sponsor: Berner ViszeralchirurgieKlinik Beau Site Bern

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-08-25
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 180

Inclusion Criteria

Pancreaticoduodenectomy for pancreatic carcinoma, <20% body weight loss, informed consent, age >= 18 years

Exclusion Criteria

Metastasized pancreatic carcinoma other than lymph node metastases, parenteral nutrition, secondary tumor, active chronic gastrointestinal disease, stop of the complementary nutrition for more than 3 days, cardial or renal diseases as a contraindication for the enteral complementary nutrition.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Morbidity 12 weeks postoperatively, graded according to the Clavien-Dindo classification

Secondary Outcome Measures

Name	Time	Method
- Quality of Life (QLQ-PAN26, QLQ-PAN30)<br>- Total Energy Intake<br>- Nutritional status und Bodycomposition (Muscle-, Fatmass, etc.)<br>-Survival<br>-Delay, abortion of adjuvanten treatments<br>